business
Novo Nordisk’s next obesity battlefront: Winning beyond America
Key takeaways
- Livestream Menu Make Itselect USAINTLLivestream Search quotes, news & videos Livestream Watchlist SIGN INCreate free account Markets Business Investing Tech Politics Video Watchlist Investing Club PROLivestream Menu
- Novo Nordisk has told CNBC how it is preparing to go "all in" on launching its Wegovy pill outside the U.S, as the battle for dominance of the weight-loss market goes global.
- "When we launch, we'll go all in," Novo's Executive Vice President for International Operations, Emil Kongshøj Larsen, told CNBC in an interview on Tuesday.
Livestream Menu Make Itselect USAINTLLivestream Search quotes, news & videos Livestream Watchlist SIGN INCreate free account Markets Business Investing Tech Politics Video Watchlist Investing Club PROLivestream Menu
Novo Nordisk has told CNBC how it is preparing to go "all in" on launching its Wegovy pill outside the U.S, as the battle for dominance of the weight-loss market goes global.
"When we launch, we'll go all in," Novo's Executive Vice President for International Operations, Emil Kongshøj Larsen, told CNBC in an interview on Tuesday. "It's a major opportunity."
Article preview — originally published by CNBC. Full story at the source.
Read full story on CNBC →
More top stories
Also covered by
Aggregated and edited by the Scoop newsroom. We surface news from CNBC alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop